Join the Cetuximab group to help and get support from people like you.
Cetuximab News
ASCO: Encorafenib + Cetuximab + Chemo Lengthens Survival in Metastatic CRC
FRIDAY, May 30, 2025 – For patients with BRAF V600E-mutated metastatic colorectal cancer, progression-free and overall survival are significantly longer with encorafenib plus cetuximab (EC) plus...
Dual-Targeted Therapies Plus Chemo Improve Objective Response Rate in BRAF V600E Metastatic CRC
TUESDAY, Feb. 4, 2025 – For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard chemotherapy (modified folinic acid [or levofolinate],...
There's a Best Option for Patients With Head-and-Neck Cancer Who Can't Take Cisplatin
TUESDAY, Nov. 26, 2024 – Cisplatin is the go-to chemotherapy for people battling head-and-neck cancers, but nearly a third of patients can't tolerate its side effects and quit the drug. A new trial...
FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
SILVER SPRING, Md., Nov. 7, 2011 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage...
Further information
Related condition support groups
Colorectal Cancer, Non-Small Cell Lung Cancer